Prevention and treatment of cerebral amyloid angiopathy

Details for Australian Patent Application No. 2008242648 (hide)

Owner Wyeth Janssen Alzheimer Immunotherapy

Inventors Games, Kate Dora; Schroeter, Sally

Agent Spruson & Ferguson

Pub. Number AU-A-2008242648

PCT Pub. Number WO2008/131298

Priority 60/925,228 18.04.07 US

Filing date 18 April 2008

Wipo publication date 30 October 2008

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

12 November 2009 PCT application entered the National Phase

  PCT publication WO2008/131298 Priority application(s): WO2008/131298

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Janssen Alzheimer Immunotherapy; Wyeth LLC

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008242650-Access device

2008242633-Methods of protein production using anti-senescence compounds